Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’ - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue ESC Heart Failure Année : 2019

Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’

Résumé

While anti-cancer therapies, including chemotherapy, immunotherapy, radiotherapy, and targeted therapy, are constantly advancing, cardiovascular toxicity has become a major challenge for cardiologists and oncologists. This has led to an increasing demand of cardio-oncology units in Europe and a growing interest of clinicians and researchers. The Heart Failure 2019 meeting of the Heart Failure Association of the European Society of Cardiology in Athens has therefore created a scientific programme that included four dedicated sessions on the topic along with several additional lectures. The major points that were discussed at the congress included the implementation and delivery of a cardio-oncology service, the collaboration among cardio-oncology experts, and the risk stratification, prevention, and early recognition of cardiotoxicity. Furthermore, sessions addressed the numerous different anti-cancer therapies associated with cardiotoxic effects and provided guidance on how to treat cancer patients who develop cardiovascular disease before, during, and after treatment.
Fichier principal
Vignette du fichier
EHF2-6-1140.pdf (369.82 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

inserm-03935774 , version 1 (12-01-2023)

Identifiants

Citer

Markus S Anker, Sara Hadzibegovic, Alessia Lena, Yury Belenkov, Jutta Bergler‐klein, et al.. Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’. ESC Heart Failure, 2019, 6 (6), pp.1140 - 1148. ⟨10.1002/ehf2.12551⟩. ⟨inserm-03935774⟩
28 Consultations
28 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More